Find a list of 454 Life Sciences™'s press releases below:

• 6/12/2008
  One Run - Done: 454 Sequencing Quickly Reveals Detailed Insights Into the Physiology of Corynebacterium kroppenstedtii
  Researchers at Bielefeld University in Germany have used a single sequencing run to completely assemble and characterize the genome of Corynebacterium kroppenstedtii.
• 6/11/2008
  454 Sequencing Joins the International 1000 Genomes Project
  Continuing Roche’s commitment to support human genomic research, 454 Sequencing will deliver results of the highest quality and completeness to international research effort.
• 6/5/2008
  454 Sequencing for Melon Research in Spain
  Study at the Center of Research in Agronomics in Barcelona, Spain focuses on the de novo sequencing of the musk melon
• 5/30/2008
  454 Life Sciences, Cogenics, and Limagrain to Jointly Develop Solutions for Crop SNP Discovery with Next Generation Sequencing
  Partners Will Co-Develop Genomic Complexity Reduction Methods for Crop Genomes Initial Study to Focus on Wheat Genome
• 5/21/2008
  454 Sequencing Used at Institute of Genomics & Integrative Biology (IGIB) in India
  IGIB plans to use their new Genome Sequencer FLX System system for all applications possible within this revolutionary technology, with a special focus on metagenomics and de novo genome sequencing
• 5/8/2008
  454 Sequencing for the Characterization of the Protective Intestinal Flora
  
• 4/30/2008
  Reconstructing Oetzi's, the Neolithic Man family tree with 454 Sequencing
  Reconstructing Oetzi’s family tree with 454 Sequencing gives unprecedented insight into Neolithic Man.
• 4/17/2008
  Researchers Use 454 Sequencing to Publish the Complete Genome of an Individual Human, Achieving a Key Milestone on the Path to Personalized Genome Sequencing
  Study in Nature establishes quality standard for the routine sequencing of humans
• 4/16/2008
  Top European Service provider GATC ramps up its fleet of next-gen sequencers with second GS FLX
  GATC Biotech, one of Europe’s leading sequencing service providers, has acquired a second Genome Sequencer FLX System.
• 4/15/2008
  MWG Biotech purchases second Genome Sequencer FLX system to expand capacities in line with growing sequencing demand
  MWG Biotech, a European market leader in genome sequencing services, is further expanding its 454 Sequencing capacity in order to meet the demands of a steadily increasing number of sequencing customers across Europe.
• 2/25/2008
  Researchers Use Transcriptome Analysis by 454 Sequencing to Identify Tumor Specific Mutations Linked to Malignent Pleural Mesothelioma
  Researchers have used the 454 long-read sequencing technology to characterize for the first time mutations in expressed genes unique to malignant pleural mesotheliomas (MPMs)
• 2/8/2008
  Transplantation Safety: New Virus Detected Using Genome Sequencer Technology
  Researchers at Columbia University and Victorian Infectious Disease Reference Laboratory have discovered a new virus that was responsible for the deaths of three transplant recipients.
• 2/7/2008
  The Genome Sequencing Center at Washington University School of Medicine increases fleet of Roche Genome Sequencer FLX Systems to Eight Instruments
  The Genome Sequencing Center at Washington University School of Medicine increased its sequencing capacity with an agreement to acquire five additional Genome Sequencer FLX Systems from Roche Diagnostics.
• 2/4/2008
  Roche Further Improves Cost Effectiveness and Application Versatility in Sequencing: New Long-Tag Paired End Reads and Multiplex Identifiers for the Genome Sequencer FLX System
  454 Life Sciences, a part of Roche Applied Science, today announced the launch of new products and software for the ultra-high throughput Genome Sequencer FLX System (GS FLX)
• 12/19/2007
  Researchers use the Genome Sequencer System to sequence and assemble the Pinot Noir Genome.
  Researchers from the Istituto Agrario San Michele all'Adige and Myriad Genetics have used the Genome Sequencer 20 System, to sequence and assemble the genome of the grape species Pinot Noir.
• 11/12/2007
  The Max Planck Institute in Leipzig acquires second Genome Sequencing FLX™ System.
  454 Life Sciences, a part of Roche Applied Science, today announced that the Max Planck Institute for Evolutionary Anthropology in Leipzig, Germany has purchased its second Genome Sequencer FLX (GS FLX) System.
• 11/6/2007
  A Life Sciences Renaissance: 100th peer-reviewed publication enabled by 454 Sequencing™
  454 Life Sciences, a Roche company, today announced the publication of over 100 peer-reviewed studies using the Company’s Genome Sequencer System.
• 10/23/2007
  The Human Genome Sequencing Center at Baylor College of Medicine increases fleet of Roche Genome Sequencer FLX Systems to 10 Instruments
  The Human Genome Sequencing Center at Baylor College of Medicine boosted its sequencing capabilities with an agreement to acquire seven additional Genome Sequencer FLX Systems from 454 Life Sciences, a Roche company.
• 9/27/2007
  New Pharmacogenomic Approach: 454 Life Science and Perlegen to Collaborate in Drug Response Sequencing Study
  454 Life Sciences, a Roche company, and Perlegen Sciences, Inc., today announced a collaboration to conduct large scale genetic re-sequencing for drug response.
• 9/27/2007
  454 Sequencing™: Science Paper Suggests that Structural Variation Plays an Important Role in Genetic Variation
  454 Life Sciences, a Roche company, in collaboration with Yale University researchers today announced that they have developed a method to identify significant human genetic variability with an unprecedented level of detail.
• 9/27/2007
  454 Sequencing™: Science Paper describes a novel, highly efficient method of sequencing ancient DNA, and sequences the mitochondria of 10 individual Mammoths to prove it.
  454 Life Sciences, a Roche company, today reported that researchers from Pennsylvania State University have used the company’s Genome Sequencer™ FLX system to sequencing the entire mitochondrial genomes from 10 individual woolly mammoths.
• 9/27/2007
  Versatility of 454 Sequencing™ Demonstrated in Three Publications in Science this Week
  454 Life Sciences, a Roche company, is the subject of three ground-breaking studies published this week in Science, all of which employed the company’s Genome Sequencer™ system.
• 9/27/2007
  454 Sequencing™ in Science Today: Researchers Uncover a Genetic Basis for Different Social Behaviors in Wasp.
  454 Life Sciences, a Roche company, in collaboration with researchers from the University of Illinois at Urbana-Champaign today announced that they have uncovered genetic underpinnings to social behavior in wasps.
• 9/6/2007
  Researchers Identify Virus Possibly Responsible for Declining Honeybee Population Using 454 Sequencing Technology from Roche
  454 Life Sciences, a Roche company, today announced that researchers at Columbia University, in collaboration with 454, have identified a virus implicated in the deaths of 2.4 million honeybee colonies using the company’s Genome Sequencer™ system.
• 8/30/2007
  Roche Applied Science and 454 Life Sciences improve the Genome Sequencer FLX workflow and help reduce instrument run costs
  454 Life Sciences, the sequencing center of excellence of Roche Applied Science today announced the launch of new products and software for the ultra high-throughput Genome Sequencer FLX System (GS FLX).
• 6/15/2007
  454 Sequencing(TM) Identifies HIV Drug Resistance at Early Stage
  - Retrospective study shows that even the lowest levels of resistance mutations can lead to early treatment failure -
• 5/31/2007
  454 Life Sciences and Baylor College of Medicine Complete Sequencing of DNA Project
  -The Genome of James Watson is the First to be Sequenced for Less than $1 Million-
• 5/29/2007
  454 LIFE SCIENCES ANNOUNCES THE COMPLETION OF ITS ACQUISITION BY ROCHE
  The acquisition of 454 Life Sciences by Roche is finalized and made official.
• 3/29/2007
  CuraGen Announces Definitive Agreement to Sell 454 Life Sciences to Roche
  CuraGen Corporation (Nasdaq: CRGN) and Roche today announced that 454 Life Sciences and Roche have signed a definitive merger agreement under which Roche will acquire 454 Life Sciences Corporation, a majority-owned subsidiary of CuraGen Corporation.
• 3/1/2007
  454 Sequencing Reveals Novel Aspects of a Human Pathogen
  454 Life Sciences Corp. today announced that researchers at Yale University using the company's Genome Sequencer system have determined the pathogenic content of A. baumannii.
• 1/8/2007
  454 Life Sciences Ships First Genome Sequencer FLX System(TM) to Roche Diagnostics
  454 Life Sciences Corporation today announced that the new high throughput Genome Sequencer FLX System(TM) (GS FLX) has been shipped to its marketing partner Roche Diagnostics in preparation for a first quarter 2007 launch.
• 12/21/2006
  454 Sequencing Reveals New Class of Small RNAs
  454 Life Sciences Corporation today announced that researchers have uncovered a new class of small, non-coding RNAs in worms. Application by Massachusetts Institute of Technology Yields New Insights on Gene Regulation
• 12/19/2006
  The World Economic Forum Announces Technology Pioneers 2007: 454 Life Sciences Selected
  The World Economic Forum recently announced the 47 Technology Pioneers for 2007. 454 Life Sciences Corporation has been selected as one of these Technology Pioneers.